Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia

3 Jul 2012

Abstract excerpt

Infections due to multidrug-resistant (MDR) Pseudomonas aeruginosa are increasing. The aim of our study was to evaluate the influences of appropriate empirical antibiotic therapy and multidrug resistance on mortality in patients with bacteremia due to P. aeruginosa (PAB). Episodes of PAB were prospectively registered from 2000 to 2008. MDR was considered when the strain was resistant to ≥3 antipseudomonal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotic Use and Resistance
Share to Antibiotics Pharmacokinetics and Efficacy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22751533
DOI: 10.1128/aac.00750-12

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa BacteremiaPMID 22751533Read ↗

Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes.Semantic proximity Read ↗

Clinical features and risk factors for pyogenic liver abscess caused by multidrug-resistant organisms: A retrospective studySemantic proximity Read ↗

Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance BreakpointSemantic proximity Read ↗

Risk factors for mortality in pseudomonas aeruginosa bacteremia in childrenSemantic proximity Read ↗

Epidemiology and Outcome of Pseudomonas aeruginosa Bacteremia, With Special Emphasis on the Influence of Antibiotic TreatmentSemantic proximity Read ↗

Clinical and microbiological features of infections caused by Pseudomonas aeruginosa in patients hospitalized in intensive care units.Semantic proximity Read ↗

Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.Semantic proximity Read ↗

The Impact of Infectious Diseases Consultation on the Management and Outcomes of Pseudomonas aeruginosa Bacteraemia in Adults: A Retrospective Cohort Study.Semantic proximity Read ↗

Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002.Semantic proximity Read ↗

Multidrug-Resistant <i>Pseudomonas Aeruginosa</i> Bloodstream Infections: Analysis of Trends in Prevalence and EpidemiologySemantic proximity Read ↗

Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic reviewSemantic proximity Read ↗

Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.